Roche Diagnostics serves customers spanning the entire healthcare spectrum - from commercial laboratories, research institutions and hospitals to physicians and patients.
Medical and lab professionals together play a key role in delivering optimal patient care, yet they face intensifying pressure...
Roche launches VENTANA PD-L1 (SP142) Assay in CE markets as first companion diagnostic to identify triple-negative breast cancer patients eligible for treatment.
Roche Diagnostics serves customers spanning the entire healthcare spectrum - from commercial laboratories, research institutions and hospitals to physicians and patients.
Doing now what patients need next
We believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future.
Get to know Roche
Get a real taste of the business and culture of one of the world’s great research-based healthcare companies.